Using brain signals to control devices for movement and speech
Official title: A High-Performance ECoG-based Neural Interface for Communication and Neuroprosthetic Control
Run by University of California, San Francisco · NCT03698149 · Data updated 2026-11-12
This study is testing if people with severe neurological disorders can use brain signals to control devices that help them move and speak better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 3 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | November 9, 2018 |
| Main results expected | August 15, 2030 |
| Study ends | August 15, 2030 |
| Registry record updated | May 5, 2026 |
| Trial ID | NCT03698149 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 21 with limited upper limb mobility due to conditions like ALS, spinal cord injury, or stroke, and who have a significant loss of independence.
✕Probably not a fit
Patients who are pregnant, unable to understand English, or have severe psychiatric conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study tests the feasibility of using electrocorticography (ECoG) signals to enable adults with severe neurological disorders to control complex devices for motor and speech functions. Participants will have electrodes placed on the surface of their brains to record electrical activity, which will be used to train them in controlling a robotic system. The study aims to assess whether these brain signals can facilitate speech production, providing a new avenue for communication and mobility for affected individuals.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life for patients with severe neurological impairments by restoring their ability to communicate and control devices.
How similar studies have gone: Other studies using ECoG for motor and speech control have shown promise, indicating that this approach is both innovative and grounded in prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age \> 21 2. Limited ability to use upper limbs, based on neurological examination, due to stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis, cervical spinal cord injury, brainstem stroke, muscular dystrophy, myopathy or severe neuropathy. 3. Disability, defined by a 4 or greater score on the Modified Rankin Scale, must be severe enough to cause loss of independence and inability to perform activities of daily living. 4. If stroke or spinal cord injury, at least 1 year has passed since onset of symptoms 5. Must live within a two-hour drive of UCSF Exclusion Criteria: 1. Pregnancy or breastfeeding 2. Inability to understand and/or read English 3. Inability to give consent 4. Dementia, based on history, physical exam, and MMSE 5. Active depression (BDI \> 20) or other psychiatric illness (active general anxiety disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder (OCD), or personality disorders (e.g. multiple personality disorder, borderline personality disorder, etc.) 6. History of suicide attempt or suicidal ideation 7. History of substance abuse 8. Co-morbidities including ongoing anticoagulation, uncontrolled hypertension, cancer, or major organ system failure 9. Inability to comply with study follow-up visits 10. Any prior intracranial surgery 11. History of seizures 12. Immunocompromised 13. Has an active infection 14. Has a CSF drainage system or an active CSF leak 15. Requires diathermy, electroconvulsive therapy (ECT), or transcranial magnetic stimulation (TMS) to treat a chronic condition 16. Has an implanted electronic device such as a neurostimulator, cardiac pacemaker/defibrillator or medication pump, or presence of any head or neck metallic foreign bodies 17. Allergies or known hypersensitivity to materials in the Blackrock NeuroPort Array (i.e. silicone, titanium) or the PMT Subdural Cortical Electrode (silicone, platinum iridium, nichrome)
Where it's running
-
University of California San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Karunesh Ganguly, MD, PhD — University of California, San Francisco
- Study coordinator: Adelyn Tu-Chan
- Email: adelyn.tu@ucsf.edu
- Phone: (415) 575-0431
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Robotic upper-limb therapy with built-in cognitive exercises for people with Parkinson's, MS, or stroke
This trial will test whether sensor-based robotic arm training that includes thinking exercises can help adults with Parkinson's disease, multiple sclerosis, or stroke improve attention, memory, and arm movement.
-
Mollii neuromodulation suit to improve function and quality of life after stroke or multiple sclerosis
This trial will test whether wearing the Mollii neuromodulation suit can improve mobility, balance, gait, and quality of life for people with stroke or multiple sclerosis.
-
Hypnosis to improve attention and reduce fatigue in stroke, TBI, and MS
This trial tests whether adding hypnosis to standard rehab can help adults with stroke, traumatic brain injury, or multiple sclerosis improve attention and feel less fatigued.
-
Can a powered ankle brace help people with foot drop walk faster
This study tests whether the NEUROSWING orthosis can improve walking speed in adults with dorsal and/or plantar flexor deficits compared with a carbon brace.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.